{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:41:38Z","timestamp":1790343698161,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Biotechnology, India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12035-021-02456-0","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T21:02:30Z","timestamp":1624654950000},"page":"4745-4757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Involvement of Peroxiredoxin-3, Thioredoxin-2, and Protein Deglycase-1 in Cypermethrin-Induced Parkinsonism"],"prefix":"10.1007","volume":"58","author":[{"given":"Charul","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alika","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2456_CR1","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:10713. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2456_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18(2):101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2456_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4161\/auto.22443","volume":"9","author":"DM Ardu\u00edno","year":"2013","unstructured":"Ardu\u00edno DM, Esteves AR, Cardoso SM (2013) Mitochondria drive autophagy pathology via microtubule disassembly: a new hypothesis for Parkinson disease. Autophagy 9(1):112\u2013114. https:\/\/doi.org\/10.4161\/auto.22443","journal-title":"Autophagy"},{"issue":"2","key":"2456_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2478\/aiht-2019-70-3263","volume":"70","author":"H Mohammadi","year":"2019","unstructured":"Mohammadi H, Ghassemi-Barghi N, Malakshah O, Ashari S (2019) Pyrethroid exposure and neurotoxicity: a mechanistic approach. Arh Hig Rada Toksikol 70(2):74\u201389. https:\/\/doi.org\/10.2478\/aiht-2019-70-3263","journal-title":"Arh Hig Rada Toksikol"},{"issue":"1","key":"2456_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/157015912799362779","volume":"10","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Prakash O, Singh MP (2012) A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration. Curr Neuropharmacol 10(1):64\u201371. https:\/\/doi.org\/10.2174\/157015912799362779","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"2456_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","volume":"33","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakesh O, Singh MP (2012) Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33(2):404\u2013415. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.02.018","journal-title":"Neurobiol Aging"},{"key":"2456_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pestbp.2020.02.013","volume":"165","author":"L Zhou","year":"2020","unstructured":"Zhou L, Zhou M, Tan H, Xiao M (2020) Cypermethrin-induced cortical neurons apoptosis via the Nrf2\/ARE signaling pathway. Pestic Biochem Physiol 165:104547. https:\/\/doi.org\/10.1016\/j.pestbp.2020.02.013","journal-title":"Pestic Biochem Physiol"},{"key":"2456_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jspr.2019.05.001","volume":"83","author":"M Gourgouta","year":"2019","unstructured":"Gourgouta M, Rumbos CI, Athanassiou CG (2019) Residual toxicity of a commercial cypermethrin formulation on grains against four major storage beetles. J Stored Prod Res 83:103\u2013109. https:\/\/doi.org\/10.1016\/j.jspr.2019.05.001","journal-title":"J Stored Prod Res"},{"issue":"11","key":"2456_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/tox.22147","volume":"31","author":"G Eraslan","year":"2016","unstructured":"Eraslan G, Kanbur M, Silig Y, Karabacak M, Sarica ZS, Sahin S (2016) The acute and chronic toxic effect of cypermethrin, propetamphos, and their combinations in rats. Environ Toxicol 31(11):1415\u20131429. https:\/\/doi.org\/10.1002\/tox.22147","journal-title":"Environ Toxicol"},{"issue":"12","key":"2456_CR10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3109\/10715762.2010.512041","volume":"44","author":"MN Tiwari","year":"2010","unstructured":"Tiwari MN, Singh AK, Ahmad I, Upadhyay G, Singh D, Patel DK, Singh C, Prakash O, Singh MP (2010) Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic Res 44(12):1416\u20131424. https:\/\/doi.org\/10.3109\/10715762.2010.512041","journal-title":"Free Radic Res"},{"issue":"4","key":"2456_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s13105-014-0359-7","volume":"70","author":"P Tripathi","year":"2014","unstructured":"Tripathi P, Singh A, Agrawal S, Prakash O, Singh MP (2014) Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to parkinsonism. J Physiol Biochem 70(4):915\u2013924. https:\/\/doi.org\/10.1007\/s13105-014-0359-7","journal-title":"J Physiol Biochem"},{"issue":"2","key":"2456_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12035-014-8696-7","volume":"51","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Singh A, Tripathi P, Mishra M, Singh PK, Singh MP (2015) Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study. Mol Neurobiol 51(2):448\u2013465. https:\/\/doi.org\/10.1007\/s12035-014-8696-7","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2456_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s12035-014-8954-8","volume":"52","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Dixit A, Singh A, Tripathi P, Singh D, Patel DK, Singh MP (2015) Cyclosporine A and MnTMPyP alleviate \u03b1-synuclein expression and aggregation in cypermethrin-induced parkinsonism. Mol Neurobiol 52(3):1619\u20131628. https:\/\/doi.org\/10.1007\/s12035-014-8954-8","journal-title":"Mol Neurobiol"},{"issue":"36","key":"2456_CR14","doi-asserted-by":"publisher","first-page":"27850","DOI":"10.1074\/jbc.M110.101196","volume":"285","author":"DA Drechsel","year":"2010","unstructured":"Drechsel DA, Patel M (2010) Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin\/peroxiredoxin system. J Biol Chem 285(36):27850\u201327858. https:\/\/doi.org\/10.1074\/jbc.M110.101196","journal-title":"J Biol Chem"},{"issue":"2","key":"2456_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BJ20091541","volume":"425","author":"AG Cox","year":"2009","unstructured":"Cox AG, Winterbourn CC, Hampton MB (2009) Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signaling. Biochem J 425(2):313\u2013325. https:\/\/doi.org\/10.1042\/BJ20091541","journal-title":"Biochem J"},{"issue":"52","key":"2456_CR16","doi-asserted-by":"publisher","first-page":"40699","DOI":"10.1074\/jbc.M110.185827","volume":"285","author":"EM Hanschmann","year":"2010","unstructured":"Hanschmann EM, Lonn ME, Schutte LD, Funke M, Godoy JR, Eitner S, Hudemann C, Lillig CH (2010) Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3. J Biol Chem 285(52):40699\u201340705. https:\/\/doi.org\/10.1074\/jbc.M110.185827","journal-title":"J Biol Chem"},{"issue":"9","key":"2456_CR17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/jcm8091377","volume":"8","author":"M Repici","year":"2019","unstructured":"Repici M, Giorgini F (2019) DJ-1 in Parkinson\u2019s disease: clinical insights and therapeutic perspectives. J Clin Med 8(9):1377. https:\/\/doi.org\/10.3390\/jcm8091377","journal-title":"J Clin Med"},{"issue":"41","key":"2456_CR18","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1073\/pnas.0607260103","volume":"103","author":"CM Clements","year":"2006","unstructured":"Clements CM, McNally RS, Conti BJ, Mak TW, Ting JPY (2006) DJ-1, a cancer- and Parkinson\u2019s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103(41):15091\u201315096. https:\/\/doi.org\/10.1073\/pnas.0607260103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2456_CR19","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1093\/hmg\/dds131","volume":"21","author":"JY Im","year":"2012","unstructured":"Im JY, Lee KW, Woo JM, Junn E, Mouradian MM (2012) DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 21(13):3013\u20133024. https:\/\/doi.org\/10.1093\/hmg\/dds131","journal-title":"Hum Mol Genet"},{"key":"2456_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.redox.2014.04.010","volume":"2","author":"P Lopert","year":"2014","unstructured":"Lopert P, Patel M (2014) Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption. Redox Biol 2:667\u2013672. https:\/\/doi.org\/10.1016\/j.redox.2014.04.010","journal-title":"Redox Biol"},{"issue":"3","key":"2456_CR21","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.3892\/mmr.2015.3947","volume":"12","author":"YF Yan","year":"2015","unstructured":"Yan YF, Yang WJ, Xu Q, Chen HP, Huang XS, Qiu LY, Liao ZP, Huang QR (2015) DJ-1 upregulates anti-oxidant enzymes and attenuates hypoxia\/re-oxygenation-induced oxidative stress by activation of the nuclear factor erythroid 2-like 2 signaling pathway. Mol Med Rep 12(3):4734\u20134742. https:\/\/doi.org\/10.3892\/mmr.2015.3947","journal-title":"Mol Med Rep"},{"issue":"9","key":"2456_CR22","first-page":"842","volume":"171","author":"LF Van Pelt","year":"1997","unstructured":"Van Pelt LF (1997) Ketamine and xylazine for surgical anesthesia in rats. J Am Vet Med Assoc 171(9):842\u2013844","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"2456_CR23","first-page":"199","volume":"131","author":"HJ Gamble","year":"1980","unstructured":"Gamble HJ (1980) A stereotaxic atlas of the rat brain. J Anat 131(1):199\u2013200","journal-title":"J Anat"},{"issue":"7","key":"2456_CR24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/jnr.24420","volume":"97","author":"E O\u2019Neill","year":"2019","unstructured":"O\u2019Neill E, Goisis RC, Haverty R, Harkin A (2019) L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson\u2019s disease in male rats. J Neurosci Res 97(7):804\u2013816. https:\/\/doi.org\/10.1002\/jnr.24420","journal-title":"J Neurosci Res"},{"issue":"2","key":"2456_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12640-017-9800-3","volume":"33","author":"AK Mishra","year":"2018","unstructured":"Mishra AK, Mishra S, Rajput C, Rasheed MSU, Patel DK, Singh MP (2018) Cypermethrin activates autophagosome formation albeit inhibits autophagy owing to poor lysosome quality: relevance to Parkinson\u2019s disease. Neurotox Res 33(2):377\u2013387. https:\/\/doi.org\/10.1007\/s12640-017-9800-3","journal-title":"Neurotox Res"},{"key":"2456_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbadis.2013.03.019","volume":"8","author":"A Dixit","year":"1832","unstructured":"Dixit A, Srivastava G, Verma D, Mishra M, Singh PK, Prakash O (1832) Singh MP (2013) Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson\u2019s disease. Biochim Biophys Acta 8:1227\u20131240. https:\/\/doi.org\/10.1016\/j.bbadis.2013.03.019","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2456_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u2013275 (PMID:14907713)","journal-title":"J Biol Chem"},{"issue":"4","key":"2456_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3(4):461\u2013491. https:\/\/doi.org\/10.3233\/JPD-130230","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"2456_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18(6):e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"key":"2456_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2741\/4521","volume":"22","author":"IG Onyango","year":"2017","unstructured":"Onyango IG, Khan SM, Bennett JP Jr (2017) Mitochondria in the pathophysiology of Alzheimer\u2019s and Parkinson\u2019s diseases. Front Biosci (Landmark Ed) 22:854\u2013872. https:\/\/doi.org\/10.2741\/4521","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"2456_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.abb.2007.05.001","volume":"465","author":"H Zhang","year":"2007","unstructured":"Zhang H, Go YM, Jones DP (2007) Mitochondrial thioredoxin-2\/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 465(1):119\u2013126. https:\/\/doi.org\/10.1016\/j.abb.2007.05.001","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"2456_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2007.12.068","volume":"433","author":"S De Simoni","year":"2008","unstructured":"De Simoni S, Goemaere J, Knoops B (2008) Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+. Neurosci Lett 433(3):219\u2013224. https:\/\/doi.org\/10.1016\/j.neulet.2007.12.068","journal-title":"Neurosci Lett"},{"issue":"2","key":"2456_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/toxsci\/kfr058","volume":"121","author":"JR Roede","year":"2011","unstructured":"Roede JR, Hansen JM, Go YM, Jones DP (2011) Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin\/thioredoxin system. Toxicol Sci 121(2):368\u2013375. https:\/\/doi.org\/10.1093\/toxsci\/kfr058","journal-title":"Toxicol Sci"},{"key":"2456_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/683920","volume":"2013","author":"H Ariga","year":"2013","unstructured":"Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SMM (2013) Neuroprotective function of DJ-1 in Parkinson\u2019s disease. Oxid Med Cell Longev 2013:683920. https:\/\/doi.org\/10.1155\/2013\/683920","journal-title":"Oxid Med Cell Longev"},{"key":"2456_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2017.08.005","volume":"108","author":"A Biosa","year":"2017","unstructured":"Biosa A, Sandrelli F, Beltramini M, Greggio E, Bubaccon L, Bisaglia M (2017) Recent findings on the physiological function of DJ-1: beyond Parkinson\u2019s disease. Neurobiol Dis 108:65\u201372. https:\/\/doi.org\/10.1016\/j.nbd.2017.08.005","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2456_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","volume":"51","author":"LP Dolgacheva","year":"2019","unstructured":"Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease. J Bioenerg Biomembr 51(3):175\u2013188. https:\/\/doi.org\/10.1007\/s10863-019-09798-4","journal-title":"J Bioenerg Biomembr"},{"key":"2456_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1326-4-23","volume":"4","author":"H Nural","year":"2009","unstructured":"Nural H, He P, Beach T, Sue L, Xia W, Shen Y (2009) Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson\u2019s disease patients. Mol Neurodegener 4:23. https:\/\/doi.org\/10.1186\/1750-1326-4-23","journal-title":"Mol Neurodegener"},{"key":"2456_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2019.02.014","volume":"135","author":"N Sharma","year":"2019","unstructured":"Sharma N, Rao SP, Kalivendi SV (2019) The deglycase activity of DJ-1 mitigates \u03b1-synuclein glycation and aggregation in dopaminergic cells: role of oxidative stress mediated downregulation of DJ-1 in Parkinson\u2019s disease. Free Radic Biol Med 135:28\u201337. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.02.014","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2456_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Motine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133(3):713\u2013726. https:\/\/doi.org\/10.1093\/brain\/awq008","journal-title":"Brain"},{"issue":"6","key":"2456_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","volume":"77","author":"O Scudamore","year":"2018","unstructured":"Scudamore O, Ciossek T (2018) Increased oxidative stress exacerbates \u03b1-synuclein aggregation in vivo. J Neuropathol Exp Neurol 77(6):443\u2013453. https:\/\/doi.org\/10.1093\/jnen\/nly024","journal-title":"J Neuropathol Exp Neurol"},{"issue":"31","key":"2456_CR41","doi-asserted-by":"publisher","first-page":"28775","DOI":"10.1074\/jbc.M505362200","volume":"280","author":"JC Moon","year":"2005","unstructured":"Moon JC, Hah YS, Kim WY, Jung BG, Jang HH, Lee JR, Kim SY, Lee YM, Jeon MG, Kim CW, Cho MJ, Lee SY (2005) Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J Biol Chem 280(31):28775\u2013287784. https:\/\/doi.org\/10.1074\/jbc.M505362200","journal-title":"J Biol Chem"},{"key":"2456_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","volume":"70","author":"SR Subramaniam","year":"2014","unstructured":"Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF (2014) Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiol Dis 70:204\u2013213. https:\/\/doi.org\/10.1016\/j.nbd.2014.06.017","journal-title":"Neurobiol Dis"},{"key":"2456_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.freeradbiomed.2016.06.019","volume":"97","author":"S Arkat","year":"2016","unstructured":"Arkat S, Umbarkar P, Singh S, Sitasawad SL (2016) Mitochondrial peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in diabetic cardiomyopathy. Free Radic Biol Med 97:489\u2013500. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.019","journal-title":"Free Radic Biol Med"},{"key":"2456_CR44","doi-asserted-by":"publisher","first-page":"4680732","DOI":"10.1155\/2017\/4680732","volume":"2017","author":"WA Garcia-Suastegui","year":"2017","unstructured":"Garcia-Suastegui WA, Ramos-Chavez LA, Rubio-Osornio M, Calvillo-Velasco M, Atzin-Mendez JA, Guevara J, Silva-Adaya D (2017) The role of CYP2E1 in the drug metabolism or bioactivation in the brain. Oxid Med Cell Longev 2017:4680732. https:\/\/doi.org\/10.1155\/2017\/4680732","journal-title":"Oxid Med Cell Longev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02456-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02456-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02456-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T18:53:42Z","timestamp":1633373622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02456-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02456-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving animals was approved by the institutional animal ethics committee. Consent to participate in the study is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}